+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anticoagulants Market by Drug Class (Direct Oral Anticoagulants, Low Molecular Weight Heparin, Unfractionated Heparin), Route Of Administration (Injectable, Oral), Indication, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Anticoagulants Market by Drug Class (Direct Oral Anticoagulants, Low Molecular Weight Heparin, Unfractionated Heparin), Route Of Administration (Injectable, Oral), Indication, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Anticoagulants Market by Drug Class (Direct Oral Anticoagulants, Low Molecular Weight Heparin, Unfractionated Heparin), Route Of Administration (Injectable, Oral), Indication, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 187 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904671
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The anticoagulants market is positioned for substantial transformation, shaped by evolving therapeutic approaches, regulatory shifts, and technology integration across global healthcare systems. Decision-makers must anticipate new challenges and capitalize on segment-specific opportunities as the environment adjusts to clinical and supply chain developments.

Market Snapshot: Anticoagulants Market Size and Growth

The anticoagulants market grew from USD 44.24 billion in 2024 to USD 48.92 billion in 2025. It is expected to continue growing at a CAGR of 10.18%, reaching USD 79.15 billion by 2030. Robust adoption is driven by heightened utilization in both acute and chronic care settings, technical innovation, and strategic realignments within the pharma industry. Regional expansion is supported by modernization in patient management and broader access to life-saving therapies.

Scope & Segmentation

A comprehensive analysis provides insight into every major segment of the anticoagulants market, examining granular dynamics across clinical and operational domains:

  • Drug Class: Direct oral anticoagulants, low molecular weight heparin, unfractionated heparin, and vitamin K antagonists
  • Route of Administration: Injectable (intravenous, subcutaneous) and oral formats
  • Indication: Atrial fibrillation, deep vein thrombosis, pulmonary embolism, venous thromboembolism prevention
  • End User: Ambulatory surgical centers, clinics, homecare settings, hospitals
  • Distribution Channel: Offline and online pharmacy
  • Regions: Americas (including US, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Companies Reviewed: Johnson & Johnson, Bayer AG, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Daiichi Sankyo Company, Limited, Sanofi S.A., Pfizer Inc., Abbott Laboratories, Amgen Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Lupin Limited, Cipla Limited

Key Takeaways: Strategic Insights Across the Anticoagulants Market

  • Direct oral anticoagulants have fundamentally changed management practices, leading to more accessible treatment outside the hospital environment and streamlined protocols for clinicians.
  • The coexistence of legacy heparin and vitamin K antagonists with newer drugs underscores the ongoing need for personalized approaches, especially in high-risk populations requiring specialized regimens.
  • Digital health adoption, including remote monitoring and patient engagement tools, is enabling more robust care transitions and real-world data collection, impacting provider decision-making and payer negotiations.
  • Regulatory adaptation is ongoing as agencies and professional societies update clinical guidelines and reimbursement models based on the latest data, affecting product adoption and hospital policies.
  • Mergers, acquisitions, and partnerships among leading biopharma and technology companies are supporting innovation in both drug development and delivery mechanisms, while enhancing pipeline diversity and regional presence.

Tariff Impact: Anticoagulant Supply Chain Adjustments Post-Policy Revision

Recent United States tariff revisions on imported pharmaceutical ingredients have driven a reassessment of global procurement and sourcing. Manufacturers are shifting strategies to manage increased production costs by diversifying supply origins and investing in domestic synthesis. Distributors and payers are renegotiating agreements to maintain affordability and consistent access to therapies, while public-private collaborations and inventory management protocols are bolstering resilience against future trade disruptions.

Methodology & Data Sources

This report synthesizes quantitative data from peer-reviewed sources, regulatory filings, and established market intelligence databases with qualitative insights from expert interviews and key opinion leader workshops. Scenario-based modeling and comparative benchmarking strengthen the validity of findings, ensuring an evidence-based strategic perspective.

Why This Report Matters

  • Delivers actionable insight for leaders navigating complexity in product portfolios and evolving clinical practices within the anticoagulants market.
  • Guides operational and investment decisions through coverage of supply chain vulnerabilities, technology integration, and regulatory considerations.
  • Supports informed strategic planning and targeted market entry or expansion efforts tailored to local and global stakeholder needs.

Conclusion

The anticoagulants market presents multi-layered growth potential and operational challenges shaped by shifting clinical preferences, policy updates, and digital transformation. This executive review empowers leaders to anticipate risk, embrace innovation, and drive value in an evolving therapeutic landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of remote patient monitoring technologies for personalized anticoagulant therapy dosing guidance
5.2. Strategic collaborations between biotech startups and established pharmaceutical firms to accelerate novel factor XI inhibitor trials
5.3. Emerging use of real-world evidence in regulatory submissions for novel anticoagulant approval pathways
5.4. Integration of artificial intelligence algorithms to predict individual bleeding risk in anticoagulant prescribing
5.5. Increasing off-label prescribing of low-dose rivaroxaban for post-operative venous thromboembolism prevention in high-risk patients
5.6. Shift towards patient-centric digital adherence tools to improve direct oral anticoagulant compliance and outcomes
5.7. Market entry dynamics of generic versions of factor Xa inhibitors following patent cliffs in major markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Anticoagulants Market, by Drug Class
8.1. Introduction
8.2. Direct Oral Anticoagulants
8.3. Low Molecular Weight Heparin
8.4. Unfractionated Heparin
8.5. Vitamin K Antagonists
9. Anticoagulants Market, by Route Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intravenous
9.2.2. Subcutaneous
9.3. Oral
10. Anticoagulants Market, by Indication
10.1. Introduction
10.2. Atrial Fibrillation
10.3. Deep Vein Thrombosis
10.4. Pulmonary Embolism
10.5. Venous Thromboembolism Prevention
11. Anticoagulants Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Clinics
11.4. Homecare Settings
11.5. Hospitals
12. Anticoagulants Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online Pharmacy
13. Americas Anticoagulants Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Anticoagulants Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Anticoagulants Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. Bayer AG
16.3.3. Boehringer Ingelheim GmbH
16.3.4. Bristol-Myers Squibb Company
16.3.5. Daiichi Sankyo Company, Limited
16.3.6. Sanofi S.A.
16.3.7. Pfizer Inc.
16.3.8. Abbott Laboratories
16.3.9. Amgen Inc.
16.3.10. Novartis AG
16.3.11. Teva Pharmaceutical Industries Ltd.
16.3.12. Dr. Reddy’s Laboratories Ltd.
16.3.13. Sun Pharmaceutical Industries Ltd.
16.3.14. Lupin Limited
16.3.15. Cipla Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTICOAGULANTS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTICOAGULANTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTICOAGULANTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTICOAGULANTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTICOAGULANTS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANTICOAGULANTS MARKET: RESEARCHAI
FIGURE 26. ANTICOAGULANTS MARKET: RESEARCHSTATISTICS
FIGURE 27. ANTICOAGULANTS MARKET: RESEARCHCONTACTS
FIGURE 28. ANTICOAGULANTS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTICOAGULANTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTICOAGULANTS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTICOAGULANTS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTICOAGULANTS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTICOAGULANTS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DIRECT ORAL ANTICOAGULANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DIRECT ORAL ANTICOAGULANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTICOAGULANTS MARKET SIZE, BY LOW MOLECULAR WEIGHT HEPARIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTICOAGULANTS MARKET SIZE, BY LOW MOLECULAR WEIGHT HEPARIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTICOAGULANTS MARKET SIZE, BY UNFRACTIONATED HEPARIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTICOAGULANTS MARKET SIZE, BY UNFRACTIONATED HEPARIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTICOAGULANTS MARKET SIZE, BY VITAMIN K ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTICOAGULANTS MARKET SIZE, BY VITAMIN K ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTICOAGULANTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTICOAGULANTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTICOAGULANTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTICOAGULANTS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTICOAGULANTS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTICOAGULANTS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTICOAGULANTS MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTICOAGULANTS MARKET SIZE, BY ATRIAL FIBRILLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DEEP VEIN THROMBOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTICOAGULANTS MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTICOAGULANTS MARKET SIZE, BY PULMONARY EMBOLISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTICOAGULANTS MARKET SIZE, BY VENOUS THROMBOEMBOLISM PREVENTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTICOAGULANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTICOAGULANTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTICOAGULANTS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTICOAGULANTS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTICOAGULANTS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTICOAGULANTS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL ANTICOAGULANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL ANTICOAGULANTS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL ANTICOAGULANTS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL ANTICOAGULANTS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL ANTICOAGULANTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL ANTICOAGULANTS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES ANTICOAGULANTS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 85. CANADA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 86. CANADA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 87. CANADA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. CANADA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. CANADA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 90. CANADA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 91. CANADA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 92. CANADA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 93. CANADA ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. CANADA ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. CANADA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. CANADA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. MEXICO ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 98. MEXICO ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 99. MEXICO ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 100. MEXICO ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 101. MEXICO ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 102. MEXICO ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 103. MEXICO ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 104. MEXICO ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 105. MEXICO ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. MEXICO ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. MEXICO ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 108. MEXICO ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 109. BRAZIL ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 110. BRAZIL ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 111. BRAZIL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 112. BRAZIL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 113. BRAZIL ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 114. BRAZIL ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 115. BRAZIL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. BRAZIL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. BRAZIL ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 118. BRAZIL ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 122. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 123. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 126. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 127. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 132. ARGENTINA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 133. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 134. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 135. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 137. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 148. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 152. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 153. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 154. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 155. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 156. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 157. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 158. UNITED KINGDOM ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 159. GERMANY ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 160. GERMANY ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 161. GERMANY ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 162. GERMANY ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 163. GERMANY ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 164. GERMANY ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 165. GERMANY ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. GERMANY ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. GERMANY ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. GERMANY ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. GERMANY ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. GERMANY ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. FRANCE ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 172. FRANCE ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 173. FRANCE ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 174. FRANCE ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 175. FRANCE ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 176. FRANCE ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 177. FRANCE ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 178. FRANCE ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 179. FRANCE ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 180. FRANCE ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 181. FRANCE ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 182. FRANCE ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 183. RUSSIA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 184. RUSSIA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 185. RUSSIA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 186. RUSSIA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 187. RUSSIA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 188. RUSSIA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 189. RUSSIA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. RUSSIA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. RUSSIA ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. RUSSIA ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. RUSSIA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. RUSSIA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. ITALY ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 196. ITALY ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 197. ITALY ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. ITALY ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. ITALY ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 200. ITALY ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 201. ITALY ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 202. ITALY ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 203. ITALY ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 204. ITALY ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 205. ITALY ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. ITALY ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. SPAIN ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 208. SPAIN ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 209. SPAIN ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. SPAIN ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. SPAIN ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 212. SPAIN ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 213. SPAIN ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 214. SPAIN ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 215. SPAIN ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. SPAIN ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. SPAIN ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 218. SPAIN ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 219. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 220. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 221. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 222. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 223. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 224. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 225. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 231. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 232. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 233. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 234. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 235. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 236. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 238. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. SAUDI ARABIA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 244. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 246. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 248. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 250. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 251. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. SOUTH AFRICA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. DENMARK ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 256. DENMARK ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 257. DENMARK ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 258. DENMARK ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 259. DENMARK ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 260. DENMARK ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 261. DENMARK ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 262. DENMARK ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 263. DENMARK ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 264. DENMARK ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 265. DENMARK ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 266. DENMARK ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 267. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 268. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 269. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 272. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 273. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 274. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 275. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 278. NETHERLANDS ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 279. QATAR ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 280. QATAR ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 281. QATAR ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 282. QATAR ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 283. QATAR ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 284. QATAR ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 285. QATAR ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. QATAR ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. QATAR ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. QATAR ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. QATAR ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 290. QATAR ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 291. FINLAND ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 292. FINLAND ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 293. FINLAND ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. FINLAND ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. FINLAND ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 296. FINLAND ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 297. FINLAND ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 298. FINLAND ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 299. FINLAND ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. FINLAND ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. FINLAND ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. FINLAND ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. SWEDEN ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 304. SWEDEN ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 305. SWEDEN ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 306. SWEDEN ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 307. SWEDEN ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 308. SWEDEN ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 309. SWEDEN ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 310. SWEDEN ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 311. SWEDEN ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. SWEDEN ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. SWEDEN ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. SWEDEN ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. NIGERIA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 316. NIGERIA ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 317. NIGERIA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 318. NIGERIA ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 319. NIGERIA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 320. NIGERIA ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 321. NIGERIA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 322. NIGERIA ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 323. NIGERIA ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 324. NIGERIA ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 325. NIGERIA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 326. NIGERIA ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 327. EGYPT ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 328. EGYPT ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 329. EGYPT ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. EGYPT ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. EGYPT ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 332. EGYPT ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 333. EGYPT ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 334. EGYPT ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 335. EGYPT ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 336. EGYPT ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 337. EGYPT ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. EGYPT ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. TURKEY ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 340. TURKEY ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 341. TURKEY ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 342. TURKEY ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 343. TURKEY ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 344. TURKEY ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 345. TURKEY ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 346. TURKEY ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 347. TURKEY ANTICOAGULANTS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 348. TURKEY ANTICOAGULANTS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 349. TURKEY ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 350. TURKEY ANTICOAGULANTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 351. ISRAEL ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 352. ISRAEL ANTICOAGULANTS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 353. ISRAEL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 354. ISRAEL ANTICOAGULANTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 355. ISRAEL ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 356. ISRAEL ANTICOAGULANTS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 357. ISRAEL ANTICOAGULANTS MARKET SIZE, BY INDICATION, 2018-2024 (U

Samples

Loading
LOADING...

Companies Mentioned

  • Johnson & Johnson
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Daiichi Sankyo Company, Limited
  • Sanofi S.A.
  • Pfizer Inc.
  • Abbott Laboratories
  • Amgen Inc.
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Lupin Limited
  • Cipla Limited

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 48.92 Billion
Forecasted Market Value ( USD ) by 2030 $ 79.15 Billion
Compound Annual Growth Rate10.1%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Acute Coronary Syndrome Therapeutics Market by Drug Class (Anticoagulants, Antiplatelet Agents, Beta Blockers), Indication (NSTEMI, STEMI, Unstable Angina), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Acute Coronary Syndrome Therapeutics Market by Drug Class (Anticoagulants, Antiplatelet Agents, Beta Blockers), Indication (NSTEMI, STEMI, Unstable Angina), Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Anticoagulant Reversal Drugs Market by Reversal Agent Type (Andexanet Alfa, Ciraparantag, Idarucizumab), Route Of Administration (Intravenous, Oral), End User, Distribution Channel, Application - Global Forecast 2025-2030 - Product Image

Anticoagulant Reversal Drugs Market by Reversal Agent Type (Andexanet Alfa, Ciraparantag, Idarucizumab), Route Of Administration (Intravenous, Oral), End User, Distribution Channel, Application - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030 - Product Image

Anticoagulants Market Size, Share & Trends Analysis Report by Drug Category (Novel Oral Anticoagulants, Direct Thrombin Inhibitors, Heparin), Route of Administration, Application, Region, with Growth Forecasts, 2025-2030

  • Report
  • 125 Pages
  • Global
From
Anticoagulants Market Report 2025 - Product Image

Anticoagulants Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Anticoagulants - Global Strategic Business Report - Product Image

Anticoagulants - Global Strategic Business Report

  • Report
  • 196 Pages
  • Global
From

About the Anticoagulant Market

The anticoagulant market within the context of cardiovascular drugs is a rapidly growing sector of the pharmaceutical industry. Anticoagulants are drugs used to prevent the formation of blood clots, which can lead to serious medical conditions such as stroke and heart attack. These drugs are used to reduce the risk of thrombosis, a condition in which a blood clot forms in a blood vessel, blocking the flow of blood. Anticoagulants are also used to treat existing blood clots, as well as to prevent the formation of new ones. The anticoagulant market is driven by the increasing prevalence of cardiovascular diseases, such as coronary artery disease, stroke, and peripheral artery disease. The rising demand for anticoagulants is also driven by the increasing aging population, as well as the increasing awareness of the importance of preventive healthcare. Some of the major companies in the anticoagulant market include Bayer AG, Bristol-Myers Squibb, Pfizer, Sanofi, and Johnson & Johnson. These companies are engaged in the development, manufacture, and marketing of anticoagulant drugs. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.